{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:34:56Z","timestamp":1785497696936,"version":"3.56.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kudzu root is commonly prescribed in traditional Chinese medicine for non-alcoholic fatty liver disease (NAFLD). Its key active ingredient, puerarin, has shown promising protective effects in experimental NAFLD models. Yet the overall efficacy and the main biological mechanisms have not been systematically assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This meta-analysis will synthesize evidence from animal studies to determine how puerarin influences liver-related outcomes in NAFLD. It will also summarize the mechanistic pathways that may account for these effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Literature retrieval was performed up to September 2025, encompassing eight databases. The risk of bias in the included studies was evaluated using the SYRCLE assessment tool. Data analyses were then performed in Stata 15. The primary outcome included triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Secondary outcome comprised interleukin-6 (IL-6), interleukin-1\u03b2 (IL-1\u03b2), tumor necrosis factor-alpha (TNF-\u03b1), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px). Subgroup analyses, publication bias assessments, and sensitivity analyses were performed to ensure the robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>20 studies were included, involving 331 animals. Puerarin treatment significantly reduced levels of TG, TC, and LDL-C, while improving HDL-C in animal models of NAFLD. Additionally, puerarin significantly upregulated antioxidant indicators SOD and GSH-Px and lowered MDA levels. Furthermore, it inhibited the expression of inflammatory factors IL-6, IL-1\u03b2, and TNF-\u03b1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This meta-analysis concludes that puerarin demonstrates substantial liver-protective effects in NAFLD models by regulating lipid metabolism, anti-inflammatory, and antioxidant. Collectively, these finding lays a solid evidence-based foundation for the subsequent advancement of clinical translation research and the in-depth exploration of its underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero<\/jats:ext-link>\n                      \/, Identifier CRD420251170089.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1795374","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:47:50Z","timestamp":1776059270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Preclinical evaluation of puerarin for the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingya","family":"Li","sequence":"first","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Meng","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"An","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Shang","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Chen","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Qi","sequence":"additional","affiliation":[{"name":"Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhi","family":"Su","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Hebei University of Chinese Medicine","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e70950","DOI":"10.1002\/fsn3.70950","article-title":"Therapeutic potential of Conyza bonariensis n-Hexane extract in non-alcoholic fatty liver disease: histological, biochemical, and in silico insights from a high-fat diet rat model","volume":"13","author":"Al Kazman","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"35160","DOI":"10.1038\/s41598-025-19208-y","article-title":"Portulaca oleracea-derived indoline amide ameliorates obesity and NAFLD in rats through Nrf2-dependent antioxidant and anti-inflammatory mechanisms","volume":"15","author":"Alshamari","year":"2025","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1186\/s12876-025-04436-3","article-title":"Therapeutic potential of Akkermansia muciniphila in non-alcoholic fatty liver disease: a systematic review","volume":"25","author":"Asghari","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving role for pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e69919","DOI":"10.7759\/cureus.69919","article-title":"Resmetirom: a systematic review of the revolutionizing approach to non-alcoholic steatohepatitis treatment focusing on efficacy, safety, cost-effectiveness, and impact on quality of life","volume":"16","author":"Bittla","year":"2024","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.13481\/j.1671-587X.20260106","article-title":"Ameliorative effect of puerarin on non-alcoholic fatty liver disease induced by high-fat diet in mice and its mechanism","volume":"52","author":"Chen","year":"2026","journal-title":"J. Jilin Univ. Med. Ed."},{"key":"B9","doi-asserted-by":"publisher","first-page":"116089","DOI":"10.1016\/j.jep.2022.116089","article-title":"Oriental traditional herbal Medicine--Puerariae flos: a systematic review","volume":"306","author":"Chen","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"106862","DOI":"10.1016\/j.fitote.2025.106862","article-title":"Shenling jianpiwei formula ameliorates metabolic associated fatty liver disease through modulation of the gut microbiota and attenuation of LPS-Mediated inflammation","volume":"186","author":"Chen","year":"2025","journal-title":"Fitoterapia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/antiox14111384","article-title":"Anti-inflammatory and antioxidant mechanisms of Dendrobium moschatum polysaccharide in intestinal epithelial cells via TLR4-NF-\u03baB and Nrf2 signaling pathways","volume":"14","author":"Chen","year":"","journal-title":"Antioxidants (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"157552","DOI":"10.1016\/j.phymed.2025.157552","article-title":"Ginsenoside Rg2 ameliorates metabolic dysfunction-related steatohepatitis via the Nrf2 pathway by suppressing inflammation, apoptosis, oxidative stress and fibrosis","volume":"149","author":"Chen","year":"","journal-title":"Phytomedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1039\/d0fo01119c","article-title":"Lactobacillus casei-fermented blueberry pomace augments sIgA production in high-fat diet mice by improving intestinal microbiota","volume":"11","author":"Cheng","year":"2020","journal-title":"Food Funct."},{"key":"B14","doi-asserted-by":"publisher","first-page":"117361","DOI":"10.1016\/j.biopha.2024.117361","article-title":"Berberine alleviates fructose-induced hepatic injury via ADK\/AMPK\/Nrf2 pathway: a novel insight","volume":"179","author":"Cheng","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-025-02483-z","article-title":"Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-\u03baB-mediated inflammation by regulating the PI3K\/AKT\/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model","volume":"24","author":"Chu","year":"2025","journal-title":"Lipids Health Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s10020-025-01304-4","article-title":"Rhein alleviates hepatic steatosis in NAFLD mice by activating the AMPK\/ACC\/SREBP1 pathway to enhance lipid metabolism","volume":"31","author":"Dai","year":"2025","journal-title":"Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.13982\/j.mfst.1673-9078.2024.4.0510","article-title":"Puerarin relieves liver metabolic disorders in mice with nonalcoholic fatty liver disease","volume":"40","author":"Ding","year":"2024","journal-title":"Mod. Food Sci. Technol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"118468","DOI":"10.1016\/j.jep.2024.118468","article-title":"Pueraria Lobata antioxidant extract ameliorates non-alcoholic fatty liver by altering hepatic fat accumulation and oxidative stress","volume":"333","author":"Dong","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"970292","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1021\/acs.jafc.3c09601","article-title":"Puerarin induces macrophage M2 polarization to exert antinonalcoholic steatohepatitis pharmacological activity via the activation of autophagy","volume":"72","author":"Fang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1042\/BCJ20210071","article-title":"SREBP-1c and lipogenesis in the liver: an update1","volume":"478","author":"Ferr\u00e9","year":"2021","journal-title":"Biochem. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2362.2002.00976.x","article-title":"Correlation between heavy alcohol consumption and elevation of matrix metalloproteinases","volume":"32","author":"Forough","year":"2002","journal-title":"Eur. J. Clin. Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"113964","DOI":"10.1016\/j.jpba.2021.113964","article-title":"Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing","volume":"197","author":"Gong","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3969\/j.issn.2095-8439.2019.01.111","article-title":"Effect of puerarin on fat metabolism in non-alcoholic fatty liver","volume":"6","author":"Guo","year":"2019","journal-title":"Dietetics Health Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2174\/1871523019666201228111713","article-title":"Relationship between oxidative stress, tau level and antioxidant mechanisms of the KEAP-1\/NRF-2\/HO-1 in children with hydrocephalus","volume":"20","author":"Guzelcicek","year":"2021","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7661\/j.cjim.20250530.247","article-title":"Puerarin ameliorated metabolic-associated fatty liver in mice by improving oxidative stress and inflammation","volume":"46","author":"Han","year":"2026","journal-title":"Chin. J. Integr. Traditional Chin. West. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e70394","DOI":"10.1002\/hsr2.70394","article-title":"A new hope for the patients of non-alcoholic steatohepatitis: FDA gives green signal for resmetirom use","volume":"8","author":"Hasan","year":"2025","journal-title":"Health Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"157515","DOI":"10.1016\/j.phymed.2025.157515","article-title":"Constituents-composed Chinese medicine of dajianzhong decoction ameliorates Non-alcoholic fatty liver disease via AMPK\/PPAR\u03b1\/CPT1 signaling","volume":"149","author":"He","year":"2025","journal-title":"Phytomedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.gtc.2019.10.001","article-title":"Why do lifestyle recommendations fail in Most patients with nonalcoholic fatty liver disease?","volume":"49","author":"Hernandez Roman","year":"2020","journal-title":"Gastroenterol. Clin. North Am."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3390\/nu17111768","article-title":"Hexaraphane affects the activation of hepatic PPAR\u03b1 signaling: impact on plasma triglyceride levels and hepatic senescence with aging","volume":"17","author":"Higa","year":"2025","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.13359\/j.cnki.gzxbtcm.2021.02.026","article-title":"Puerarin alleviates nonalcoholic fatty liver disease-induced liver injury in rats by inhibiting I\u03baB\u03b1\/NF-\u03baB p65 signaling axis","volume":"38","author":"Hu","year":"2021","journal-title":"J. Guangzhou Univ. Traditional Chin. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1875-5364(23)60399-1","article-title":"Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8","volume":"21","author":"Hu","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.freeradbiomed.2025.11.005","article-title":"Ammonium tetrathiomolybdate ameliorates heat stroke-induced murine liver injury by activating the Nrf2\/HO-1 signaling pathway and inhibiting oxidative stress","volume":"242","author":"Jiang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"B34","first-page":"1540","article-title":"Protective effect of puerarin combined with aerobic exercise on SIRT1-mediated autophagy in hepatocytes in rats with non-alcoholic fatty liver disease","volume":"42","author":"Jin","year":"2020","journal-title":"Hebei J. Traditional Chin. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s10753-025-02247-y","article-title":"PARP1 exacerbates prostatitis by promoting M1 macrophages polarization through NF-\u03baB pathway","volume":"48","author":"Jin","year":"2025","journal-title":"Inflammation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"230","DOI":"10.22037\/ghfbb.v18i2.3071","article-title":"Exploring drug repurposing as a therapeutic strategy for non-alcoholic fatty liver disease (NAFLD): identification of potential targets and pathways","volume":"18","author":"Khazaei-Poul","year":"2025","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1578472","DOI":"10.3389\/fphar.2025.1578472","article-title":"Unveiling the power of pueraria Lobata: a comprehensive exploration of its medicinal and edible potentials","volume":"16","author":"Kou","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1470458","DOI":"10.3389\/fchem.2024.1470458","article-title":"Oxidative stress: fundamentals and advances in quantification techniques","volume":"12","author":"Krishnamurthy","year":"2024","journal-title":"Front. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/joim.13380","article-title":"Inflammatory and fibrotic mechanisms in NAFLD-implications for new treatment strategies","volume":"291","author":"Lee","year":"2022","journal-title":"J. Intern Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- \u03baB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.13193\/j.issn.1673-7717","article-title":"Therapeutic effect and mechanism of different intensity exercise with puerarin in rats models of nonalcoholic fatty liver disease","volume":"36","author":"Leng","year":"2018","journal-title":"Chin. Archives Traditional Chin. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.3390\/cells11213518","article-title":"Bta-miR-199a-3p inhibits LPS-induced inflammation in bovine mammary epithelial cells via the PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e13918","DOI":"10.1111\/apha.13918","article-title":"Heme oxygenase-1 prevents non-alcoholic steatohepatitis through modulating mitochondrial quality control","volume":"237","author":"Li","year":"2023","journal-title":"Acta Physiol. (Oxf)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1423634","DOI":"10.3389\/fphar.2024.1423634","article-title":"Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.2147\/JIR.S490418","article-title":"The NRF-2\/HO-1 signaling pathway: a promising therapeutic target for metabolic dysfunction-associated steatotic liver disease","volume":"17","author":"Li","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/jsfa.70293","article-title":"Antioxidative stress effect of chromium-chelated pea (pisum sativum L.) peptides through the Keap1\/Nrf2 pathway","volume":"28","author":"Li","year":"2025","journal-title":"J. Sci. Food Agric."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1652996","DOI":"10.3389\/fendo.2025.1652996","article-title":"A new perspective on non-invasive diagnosis of non-alcoholic fatty liver disease: evidence integration of inflammatory and metabolic biomarkers based on a scoping review","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B48","first-page":"335","article-title":"Puerarin alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating gut microbiota","volume":"55","author":"Ling","year":"2025","journal-title":"Ann. Clin. Lab. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/biomedicines10061250","article-title":"NF-\u03baB: a double-edged sword controlling inflammation","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1642436","DOI":"10.3389\/fendo.2025.1642436","article-title":"Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41522-025-00706-w","article-title":"Targeted metabolomics reveals bioactive inflammatory mediators from gut into blood circulation in children with NAFLD","volume":"11","author":"Luo","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e197929","DOI":"10.1172\/jci.insight.197929","article-title":"Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1\/p38MAPK\u03b1-dependent mechanisms","volume":"10","author":"Ma","year":"2025","journal-title":"JCI Insight"},{"key":"B53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1159\/000538252","article-title":"miR-21-5p modulates airway inflammation and epithelial-mesenchymal transition processes in a mouse model of combined allergic rhinitis and asthma syndrome","volume":"185","author":"Mao","year":"2024","journal-title":"Int. Arch. Allergy Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.chmed.2023.12.006","article-title":"Inula britannica ameliorates alcohol-induced liver injury by modulating SIRT1-AMPK\/Nrf2\/NF-\u03baB signaling pathway","volume":"16","author":"Meng","year":"2024","journal-title":"Chin. Herb. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"155663","DOI":"10.1016\/j.prp.2024.155663","article-title":"trans-chalcone ameliorates CCl4-induced acute liver injury by suppressing endoplasmic reticulum stress, oxidative stress and inflammation","volume":"263","author":"Munakarmi","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1134661","DOI":"10.3389\/fimmu.2023.1134661","article-title":"NF-\u03baB in monocytes and macrophages - an inflammatory master regulator in multitalented immune cells","volume":"14","author":"Mussbacher","year":"2023","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"B58","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.1039\/d3fo02988c","article-title":"Structural properties of kudzu protein enzymatic hydrolysate and its repair effect on HepG2 cells damaged by HO oxidation","volume":"14","author":"Pang","year":"2023","journal-title":"Food Funct."},{"key":"B59","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","article-title":"The role of antioxidants in the chemistry of oxidative stress: a review","volume":"97","author":"Pisoschi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"153140","DOI":"10.1016\/j.phymed.2019.153140","article-title":"Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2\/HO-1 antioxidant signaling pathway","volume":"67","author":"Qiu","year":"2020","journal-title":"Phytomedicine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1039\/d1fo04218a","article-title":"Preventive effect of Chinese dwarf cherry Cerasus humilis (Bge.) Sok. fermentation juice on dextran sulfate sodium-induced ulcerative colitis rats through the regulation of IgA and the intestinal immune barrier","volume":"13","author":"Ran","year":"2022","journal-title":"Food Funct."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/ijms20020308","article-title":"Intestinal microbiota protects against MCD diet-induced steatohepatitis","volume":"20","author":"Schneider","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"122047","DOI":"10.1016\/j.biomaterials.2023.122047","article-title":"Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis","volume":"295","author":"Shashni","year":"2023","journal-title":"Biomaterials"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e407025","DOI":"10.1590\/acb407025","article-title":"Hepatoprotective effect of lotus leaf against non-alcoholic fatty liver disease in rats via alteration of AMPK\/SIRT1 and Nrf2\/HO-1 signaling pathway","volume":"40","author":"Shen","year":"2025","journal-title":"Acta Cir. Bras."},{"key":"B68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jphs.2025.03.001","article-title":"Puerarin improves MASLD by remodeling intestinal microenvironment to promote mitochondrial fusion and autophagy","volume":"158","author":"Sun","year":"2025","journal-title":"J. Pharmacol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang","year":"2016","journal-title":"Mol. Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"103746","DOI":"10.1016\/j.fbio.2024.103746","article-title":"A Pueraria Lobata root extract alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating the gut microbiota and associated metabolites","volume":"59","author":"Tang","year":"2024","journal-title":"Food Biosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-015-0448-8","article-title":"NF-\u03baB transcriptional activation by TNF\u03b1 requires phospholipase C, extracellular signal-regulated kinase 2 and poly (ADP-ribose) polymerase-1","volume":"12","author":"Vuong","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3892\/etm.2013.1461","article-title":"Comparison between the efficacies of curcumin and puerarin in C57BL\/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet","volume":"7","author":"Wang","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/ptr.6417","article-title":"Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1\/PI3K\/AKT signaling pathway and facilitating mitochondrial homeostasis","volume":"33","author":"Wang","year":"2019","journal-title":"Phytother. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1097\/CM9.0000000000000696","article-title":"Gut microbiota and metabolic syndrome","volume":"133","author":"Wang","year":"2020","journal-title":"Chin. Med. J. Engl."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e44527","DOI":"10.1097\/MD.0000000000044527","article-title":"Global, regional, and national burden of nonalcoholic fatty liver disease (NAFLD) among people aged 15 to 49 years from 1990 to 2021, with projections to 2050: a systematic analysis based on the 2021 global burden of disease study","volume":"104","author":"Wang","year":"2025","journal-title":"Med. Baltim."},{"key":"B76","doi-asserted-by":"publisher","first-page":"157404","DOI":"10.1016\/j.phymed.2025.157404","article-title":"Integrative gut microbiota and metabolomics reveals the mechanism of chicory extract in improving metabolic dysfunction-associated steatotic liver disease via gut-liver axis","volume":"148","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"116594","DOI":"10.1016\/j.bcp.2024.116594","article-title":"Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4\/ROS\/GPX4 pathway","volume":"230","author":"Wu","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13098-025-01932-0","article-title":"Global burden of chronic liver disease due to NAFLD from 2012 to 2021: a trend, decomposition, and health inequality analysis","volume":"17","author":"Wu","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1039\/d0fo02761h","article-title":"Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway","volume":"12","author":"Xu","year":"2021","journal-title":"Food Funct."},{"key":"B80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00280-024-04668-2","article-title":"PARP1 promotes EGFR-TKI drug-resistance via PI3K\/AKT pathway in non-small-cell lung cancer","volume":"94","author":"Xu","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"118512","DOI":"10.1016\/j.biopha.2025.118512","article-title":"Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK\/SREBP1\/NF-\u03baB\/TGF-\u03b2 pathways in metabolic dysfunction-associated steatohepatitis","volume":"191","author":"Yadav","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"831168","DOI":"10.3389\/fimmu.2022.831168","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","article-title":"Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation","volume":"22","author":"Yang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e13229","DOI":"10.1590\/1414-431X2024e13229","article-title":"Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K\/AKT signaling pathway","volume":"57","author":"Yang","year":"2024","journal-title":"Braz J. Med. Biol. Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.chmed.2025.04.009","article-title":"Coptis chinensis shows distinct effects on hyperlipidemia and gut microbiota in high-fat diet induced mice with cold or hot syndrome","volume":"17","author":"Yang","year":"2025","journal-title":"Chin. Herb. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/ptr.6034","article-title":"Puerarin inhibits TRPM3\/miR-204 to promote MC3T3-E1 cells proliferation, differentiation and mineralization","volume":"32","author":"Zeng","year":"2018","journal-title":"Phytother. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"480","DOI":"10.19586\/j.2095-2341.2023.0171","article-title":"Protection of nonalcoholic fatty liver in mice by puerarin","volume":"14","author":"Zhang","year":"2024","journal-title":"Curr. Biotechnol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1142\/S0192415X25500788","article-title":"The role of traditional Chinese medicine in the management of nonalcoholic fatty liver disease: targeting gut microbiome","volume":"53","author":"Zhang","year":"","journal-title":"Am. J. Chin. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1610498","DOI":"10.3389\/fphar.2025.1610498","article-title":"Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease","volume":"16","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3736\/jcim20080909","article-title":"Effects of puerarin on expressions of leptin receptor mRNAphosphorylated janus kinase 2\/phosphorylated signal transducers and activators of transcription3proteins in the liver of rats with non-alcoholic fatty liver","volume":"6","author":"Zheng","year":"","journal-title":"J. Chin. Integr. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.16305\/j.1007-1334.2008.01.027","article-title":"Effect of puerarin on hepaticlipid of nonalcoholic fatty liver disease rats","volume":"42","author":"Zheng","year":"","journal-title":"Shanghai J. Traditional Chin. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"352","DOI":"10.11569\/wcjd.v31.i9.352","article-title":"Puerarin alleviates nonalcoholic steatohepatitis by upregulating the Nrf2 pathway","volume":"31","author":"Zhong","year":"2023","journal-title":"World Chin. J. Dig."},{"key":"B95","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"173976","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"956688","DOI":"10.3389\/fimmu.2022.956688","article-title":"Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1631\/jzus.B2400053","article-title":"Roles of the Keap1\/Nrf2 pathway and mitophagy in liver diseases","volume":"26","author":"Zhou","year":"2025","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1460643","DOI":"10.3389\/fphar.2025.1460643","article-title":"Biochemical changes associated with non-alcoholic fatty liver disease in response to berberine treatment: a systematic review and meta-analysis of clinical and preclinical research","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1795374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:47:58Z","timestamp":1776059278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1795374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":99,"alternative-id":["10.3389\/fphar.2026.1795374"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1795374","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1795374"}}